» Articles » PMID: 25853174

Amyloid Accelerates Tau Propagation and Toxicity in a Model of Early Alzheimer's Disease

Abstract

Introduction: In early stages of Alzheimer's disease (AD), neurofibrillary tangles (NFT) are largely restricted to the entorhinal cortex and medial temporal lobe. At later stages, when clinical symptoms generally occur, NFT involve widespread limbic and association cortices. At this point in the disease, amyloid plaques are also abundantly distributed in the cortex. This observation from human neuropathological studies led us to pose two alternative hypotheses: that amyloid in the cortex is permissive for the spread of tangles from the medial temporal lobe, or that these are co-occurring but not causally related events simply reflecting progression of AD pathology.

Results: We now directly test the hypothesis that cortical amyloid acts as an accelerant for spreading of tangles beyond the medial temporal lobe. We crossed rTgTauEC transgenic mice that demonstrate spread of tau from entorhinal cortex to other brain structures at advanced age with APP/PS1 mice, and examined mice with either NFTs, amyloid pathology, or both. We show that concurrent amyloid deposition in the cortex 1) leads to a dramatic increase in the speed of tau propagation and an extraordinary increase in the spread of tau to distal brain regions, and 2) significantly increases tau-induced neuronal loss.

Conclusions: These data strongly support the hypothesis that cortical amyloid accelerates the spread of tangles throughout the cortex and amplifies tangle-associated neural system failure in AD.

Citing Articles

Amyloid-β and tau deposition in traumatic brain injury: a study of Vietnam War veterans.

de Bruin H, Groot C, Kamps S, Vijverberg E, Steward A, Dehsarvi A Brain Commun. 2025; 7(1):fcaf009.

PMID: 39845735 PMC: 11752645. DOI: 10.1093/braincomms/fcaf009.


Network-based amyloid-β pathology predicts subsequent cognitive decline in cognitively normal older adults.

He H, Razlighi Q, Gazes Y, Habeck C, Stern Y bioRxiv. 2024; .

PMID: 39713320 PMC: 11661183. DOI: 10.1101/2024.12.10.627818.


Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses.

Kadamangudi S, Marcatti M, Zhang W, Fracassi A, Kayed R, Limon A Acta Neuropathol. 2024; 149(1):2.

PMID: 39688618 PMC: 11652575. DOI: 10.1007/s00401-024-02839-2.


The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage.

Chen J, Li S, Zhang F, Chen J, Cai C, Guo Y Mol Psychiatry. 2024; .

PMID: 39558004 DOI: 10.1038/s41380-024-02837-6.


Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer's Disease and Other Proteinopathies.

Kotarba S, Kozlowska M, Scios M, Saramowicz K, Barczuk J, Granek Z Int J Mol Sci. 2024; 25(19).

PMID: 39409126 PMC: 11477428. DOI: 10.3390/ijms251910797.


References
1.
Wu J, Herman M, Liu L, Simoes S, Acker C, Figueroa H . Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J Biol Chem. 2012; 288(3):1856-70. PMC: 3548495. DOI: 10.1074/jbc.M112.394528. View

2.
Polydoro M, de Calignon A, Suarez-Calvet M, Sanchez L, Kay K, Nicholls S . Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease. J Neurosci. 2013; 33(33):13300-11. PMC: 3742920. DOI: 10.1523/JNEUROSCI.0881-13.2013. View

3.
Liu L, Drouet V, Wu J, Witter M, Small S, Clelland C . Trans-synaptic spread of tau pathology in vivo. PLoS One. 2012; 7(2):e31302. PMC: 3270029. DOI: 10.1371/journal.pone.0031302. View

4.
Jellinger K, Braak H, Braak E, Fischer P . Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Ann N Y Acad Sci. 1991; 640:203-9. DOI: 10.1111/j.1749-6632.1991.tb00218.x. View

5.
Rasool S, Martinez-Coria H, Wu J, LaFerla F, Glabe C . Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice. J Neurochem. 2013; 126(4):473-82. PMC: 4105004. DOI: 10.1111/jnc.12305. View